Project objectivesThe project aims to thoroughly investigate the potential role of some chemical compounds from InMed Pharmaceuticals in modulating the various elements that make up the endocannabinoid system in human keratinocytes, in order to use them as new therapeutic approaches for various skin disorders including tumors, psoriasis, atopic dermatitis, acne vulgaris, seborrhea, and pruritus. |
Start and end date |
|
2019 - 2021 |
Project Manager |
|
Prof. Mauro Maccarrone |
Coordinating institution of the project |
|
Università Campus Bio-Medico di Roma |
Other Institutions involved |
|
University of Teramo |
Funding source(s). |
|
InMed Pharmaceuticals Inc. (Canada) |